Today: Last Update:

  • WADA Compliance Review Committee update


    The independent Compliance Review Committee (CRC) of the World Anti-Doping Agency (WADA) held its latest meeting on 27-28 May 2019 in Copenhagen, Denmark, to discuss a number of issues related to compliance with the World Anti-Doping Code (Code). In particular, these included:

    An update on the analysis of the data retrieved from the Moscow Laboratory and the way forward for cases to be followed up by the relevant International Federations (IFs).

    A review of the latest draft of the revised International Standard for Code Compliance by Signatories (ISCCS), which is being updated as part of the ongoing Code and International Standards’ review.

    An update on the implementation by IFs and National Anti-Doping Organizations (NADOs) of the corrective actions identified through WADA’s Code Compliance Questionnaire and WADA’s compliance audit program. The CRC acknowledged the continuous growth of the overall level of compliance of Code Signatories’ programs as a result of WADA’s monitoring activities. In particular, the CRC noted that IFs and NADOs belonging to Tier 1 of Code Signatories have implemented 100% of their critical and high priority corrective actions while Tier 2 IFs and NADOs have implemented 99% of critical corrective actions resulting from the Code Compliance Questionnaire.

    A review of WADA’s Compliance Monitoring Program, including the continuous monitoring program, the prioritization policy in force and the long-term strategy.

    A review of the situation of the Code Signatories that are currently on the non-compliance list.
    An update on the incorporation of Major Event Organizations into WADA’s compliance monitoring program starting in the second part of 2019.

    The CRC is responsible for providing independent advice, guidance and recommendations to WADA’s management and governing bodies on matters relating to Signatories' compliance with their obligations under the Code.

    For more information on Code compliance, please visit the Code Compliance section of WADA’s website.


    The World Anti-Doping Agency (WADA) is pleased to announce that it has coordinated the simultaneous introduction of identical hematology analyzers at all WADA-accredited and approved laboratories throughout the world to further enhance precision and consistency of doping controls carried out as part of the Athlete Biological Passport (ABP) program.

    These Sysmex XN-1000 automated hematology analyzers, which are operational globally from today (3 June), produce results that are more comparable and traceable over time.

    WADA Senior Executive Director, Sciences and International Partnerships, Dr. Olivier Rabin, said: “This is another significant step forward in the ongoing development of the ABP program around the world. In running the ABP, it is extremely important to ensure that the results of tests taken over time from athletes who move around the world can be compared and monitored with a high degree of accuracy and comparability, regardless of the testing location.

    “Importantly, these hematology analyzers function with a high degree of sensitivity and reproducibility. To date, Sysmex has actively supported WADA in the implementation of the ABP program.”

    Senior Executive Officer, Managing Director and Head of Global Marketing for Sysmex Corporation, Iwane Matsui said: “We are honored to be in partnership with WADA, supporting its steadfast commitment to eradicating doping and to fostering fair sport. The proven precision and reliability of the XN-1000, as well as its proprietary quality control service and robust support structure, will deliver globally comparable and highly reliable results that will support higher-quality, more efficient and more streamlined ABP operations globally.”

    Blood samples taken from athletes as part of the ABP program are analyzed at 30 WADA-accredited or approved laboratories around the world. The ABP was introduced in 2009 to monitor variations of athletes’ blood parameters over time, indirectly revealing blood manipulations – a method that complements conventional doping controls, which test directly for banned substances.

    As a service to our readers, Around the Rings will provide verbatim texts of selected press releases issued by Olympic-related organizations, federations, businesses and sponsors.

    These press releases appear as sent to Around the Rings and are not edited for spelling, grammar or punctuation. 

    25 Years at #1: Your best source of news about the Olympics is, for subscribers only